The long-held belief that frozen shoulder resolves on its own within a predictable timeframe is being challenged by mounting clinical evidence. This shift in understanding has significant implications for the millions of middle-aged adults who develop this debilitating condition, as it suggests more proactive treatment approaches may be warranted rather than simply waiting for natural resolution.
Adhesive capsulitis affects the shoulder joint capsule, causing it to thicken and tighten around the joint, resulting in severe pain and dramatically reduced range of motion. The condition progresses through distinct phases, with the characteristic global restriction of passive glenohumeral movement serving as the primary diagnostic criterion. Unlike other shoulder conditions, frozen shoulder demonstrates limitation in all directions of movement, a key distinguishing feature that allows clinicians to make the diagnosis through physical examination alone.
This evolving understanding represents a meaningful departure from traditional orthopedic teaching, which historically framed frozen shoulder as a self-limiting condition that would inevitably improve with time. The recognition of prolonged symptoms and incomplete recovery in many patients validates what clinicians have observed in practice and supports more aggressive early intervention strategies. Current evidence-based approaches emphasize individualized treatment protocols that consider disease stage, symptom severity, and patient-specific factors. Corticosteroid injections combined with targeted physical therapy show substantial benefit for appropriately selected patients, while surgical options remain available for cases that don't respond to conservative measures. This paradigm shift toward acknowledging the potentially chronic nature of frozen shoulder should prompt both patients and healthcare providers to pursue more proactive treatment strategies rather than adopting a purely expectant approach.